SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 24th, 2013 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 24, 2013, is by and among Navidea Biopharmaceuticals, Inc., a Delaware corporation with offices located at 425 Metro Place North, Suite 450, Dublin, Ohio (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”) (provided that if only one Buyer is listed on the Schedule of Buyers, then all references to “Buyers” hereunder shall be treated as if a reference to a single “Buyer” hereunder).
